Li Teng, Du Yue-Qi, Yin Yi-Heng, Xing Shao-Ling, Qiao Guang-Yu
Department of Neurosurgery, The First Medical Centre, 104607Chinese PLA General Hospital, Beijing, China.
Department of Anesthesia and Operative Services, The First Medical Centre, 104607Chinese PLA General Hospital, Beijing, China.
Global Spine J. 2022 Jun;12(5):909-915. doi: 10.1177/2192568220970164. Epub 2020 Nov 3.
Retrospective case series.
To evaluate the outcomes of a head frame reduction and atlantoaxial arthrodesis technique for the treatment of reducible basilar invagination (BI) and atlantoaxial dislocation (AAD).
Seventy-two reducible BI and AAD cases who were treated with the head frame reduction and atlantoaxial arthrodesis technique from June 2015 to December 2018 were retrospectively analyzed. Radiological measurements including the atlantodental interval (ADI), the height of odontoid process above Chamberlain line, Wackenheim line, clivus-canal angle (CCA) and JOA score were evaluated.
There was no death in this series. The follow-up period ranged from 6 to 32 months (mean: 21.2 months). Radiological, complete or 90% reduction was attained and complete decompression was demonstrated in all patients. The CCA increased from 123.22 ± 8.36 preoperatively to 143.05 ± 8.79 postoperatively (P < 0.01). There was no patient found postoperative dysphagia. Neurological improvement was observed in all patients, with the JOA scores increasing from 12.53 ± 1.93 preoperatively to 16.13 ± 1.23 postoperatively (P < 0.01). Solid bony fusion was demonstrated in 69 patients at follow-up (95.8%).
Head frame reduction technique is a simple and effective treatment which could relief neurologic compression and adjust the CCA in patients with reducible AAD and BI with lower potential risks. Atlantoaxial fixation with short segmental fixation, strong purchase and low shearing force could maintain superior stabilization. The safety and long-term efficacy of such fixation and reduction technique were favorable, which illustrated that it could be a promising treatment algorithm for such kind of disease.
回顾性病例系列研究。
评估头架复位及寰枢椎融合技术治疗可复位性颅底凹陷症(BI)和寰枢椎脱位(AAD)的疗效。
回顾性分析2015年6月至2018年12月采用头架复位及寰枢椎融合技术治疗的72例可复位性BI和AAD患者。评估包括寰齿间距(ADI)、齿突高于钱伯林线的高度、瓦肯海姆线、斜坡-椎管角(CCA)及日本骨科协会(JOA)评分等影像学测量指标。
本系列无死亡病例。随访时间为6至32个月(平均21.2个月)。所有患者均实现影像学上完全或90%复位,并显示完全减压。CCA从术前的123.22±8.36增加至术后的143.05±8.79(P<0.01)。未发现患者术后出现吞咽困难。所有患者神经功能均有改善,JOA评分从术前的12.53±1.93增加至术后的16.13±1.23(P<0.01)。随访时69例患者(95.8%)显示有坚固的骨融合。
头架复位技术是一种简单有效的治疗方法,可缓解神经压迫并调整可复位性AAD和BI患者的CCA,潜在风险较低。采用短节段固定、把持力强且剪切力低的寰枢椎固定可维持良好的稳定性。这种固定和复位技术的安全性和长期疗效良好,表明它可能是治疗此类疾病的一种有前景的治疗方案。